Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:17:03.039Z.
Calculation as of: 2026-10-06T16:17:03.039Z.
Quote observation: 2026-10-06T16:15:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 934548bd97ab8c390298f716fcf622fc2d1107cfab085c47b2b47650fd31fbc6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$690.28M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$672.27M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$670.50M
Free Cash Flow Yield
6.05%
TTM Avg
8.57%
3Y Avg
5.30%
5Y Avg
5.30%
Market Cap
$713.86M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$718.54M
Free Cash Flow Yield
45.69%
TTM Avg
23.39%
3Y Avg
20.43%
5Y Avg
18.16%
Market Cap
$659.73M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Helus Pharma Inc. (HELP) | $681.21M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $681.58M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $690.28M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $672.27M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $670.50M | 6.05% | 8.57% | 5.30% | 5.30% |
| OmniAb, Inc. (OABI)vs › | $654.55M | N/A | 0.14% | 0.13% | 0.13% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $713.86M | N/A | N/A | N/A | N/A |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $718.54M | 45.69% | 23.39% | 20.43% | 18.16% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $659.73M | N/A | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $717.52M | N/A | 5.55% | 5.46% | 5.46% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
